Janney Montgomery Scott’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
1,892
-1,050
-36% -$109K ﹤0.01% 2974
2026
Q1
$306K Sell
2,942
-486
-14% -$51.8K ﹤0.01% 2364
2025
Q4
$354K Sell
3,428
-315
-8% -$30.6K ﹤0.01% 2438
2025
Q3
$338K Sell
3,743
-1,062
-22% -$93K ﹤0.01% 2414
2025
Q2
$423K Sell
4,805
-50
-1% -$4.33K ﹤0.01% 2126
2025
Q1
$442K Sell
4,855
-200
-4% -$18K ﹤0.01% 2074
2024
Q4
$436K Sell
5,055
-133
-3% -$12K ﹤0.01% 2080
2024
Q3
$493K Sell
5,188
-200
-4% -$19K ﹤0.01% 1981
2024
Q2
$493K Buy
5,388
+812
+18% +$72.5K ﹤0.01% 1901
2024
Q1
$415K Sell
4,576
-50
-1% -$4.38K ﹤0.01% 2123
2023
Q4
$376K Buy
4,626
+75
+2% +$5.88K ﹤0.01% 2089
2023
Q3
$363K Buy
4,551
+100
+2% +$8.06K ﹤0.01% 2008
2023
Q2
$351K Hold
4,451
﹤0.01% 2135
2023
Q1
$346K Buy
4,451
+66
+2% +$5.09K ﹤0.01% 1964
2022
Q4
$341K Buy
+4,385
New +$323K ﹤0.01% 2028
2018
Q4
Sell
-5,601
Closed -$360K 2028
2018
Q3
$360K Buy
+5,601
New +$349K ﹤0.01% 1600

Other funds holding PPH

Janney Montgomery Scott's PPH Position: Q2 2026 in Review

Janney Montgomery Scott reduced its VanEck Pharmaceutical ETF (PPH) stake by 36% in Q2 2026, selling an estimated $109K and leaving 1,892 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2974.

Janney Montgomery Scott first reported a position in PPH in Q3 2018 and has held it in 16 quarters since. The position peaked at $493K in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Janney Montgomery Scott held 1,892 shares of VanEck Pharmaceutical ETF worth $207K as of Q2 2026.
  • Janney Montgomery Scott sold 1,050 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $109K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2974 holding.
  • Janney Montgomery Scott first reported a position in VanEck Pharmaceutical ETF in Q3 2018 and has held it in 16 quarters since.
  • Janney Montgomery Scott's VanEck Pharmaceutical ETF position peaked at $493K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.